NDC codes

FDA NDC Directory
Product NDC (as listed)69238-1607Labeler and product segments. Claims need a package NDC.
Product NDC at billing width69238-1607Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
69238-1607-6692381607061 BLISTER PACK in 1 CARTON (69238-1607-6) / 1 KIT in 1 BLISTER PACKMarketed from Oct 28, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tri Femynor
Generic name (nonproprietary)
norgestimate and ethinyl estradiol
Dosage form
Kit
Labeler
Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 203870
Marketing start
Listing expires
Identifiers
Product ID 69238-1607_1d7fbcd7-6b87-431b-9b8f-9b3722a4a186SPL ID 1d7fbcd7-6b87-431b-9b8f-9b3722a4a186SPL set ID 46bbdf70-2b80-4359-a19b-d94ff99eac98RxCUI 240128, 406396, 687424, 748797, 749784, 1862600UPC 0369238160765

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N469238160706 followed by a unit qualifier and the quantity

Package 69238-1607-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Tri Femynor is estrogen/progestin COCs, indicated for use by women to prevent pregnancy. (1.1) Tri Femynor is also indicated for the treatment of moderate acne vulgaris in females at least 15 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. Tri Femynor should be used for the treatment of acne only if the patient desires an oral contraceptive birth control. (1.2) 1.1 Oral Contraceptive Tri Femynor Tablets are indicated for use by females of reproductive potential to prevent pregnancy [ see Clinical Studies (14) ]. 1.2 Acne Tri Femynor is indicated for the treatment of moderate acne vulgaris in females at least 15 years of age, who hav…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-1607

What is NDC 69238-1607?
69238-1607 is the product NDC for Tri Femynor kit, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Tri Femynor (Norgestimate and ethinyl estradiol).
Who is the labeler?
Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tri Femynor?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in